Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, signaling a new minor update to the record. This maintenance update does not alter study details or eligibility information.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a new build of the study record.SummaryDifference0.1%

- Check33 days agoChange DetectedThe study page now shows recruitment has ended, and new navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention / Treatment heading was changed to Intervention/Treatment.SummaryDifference0.6%

- Check40 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, representing a new site build. No study details or page content were changed.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous Revision: v3.5.3. This reflects a small update to the page rendering without changes to the study data or content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, indicating a maintenance or release update to the hosting platform rather than a change to the study record content.SummaryDifference0.1%

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.